Kinsale Capital Group Inc. Purchases 1,849 Shares of Humana Inc. (NYSE:HUM)

Kinsale Capital Group Inc. lifted its position in Humana Inc. (NYSE:HUM) by 15.7% during the 4th quarter, HoldingsChannel reports. The firm owned 13,626 shares of the insurance provider’s stock after buying an additional 1,849 shares during the period. Kinsale Capital Group Inc.’s holdings in Humana were worth $3,457,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in HUM. Assenagon Asset Management S.A. increased its holdings in shares of Humana by 12.7% in the third quarter. Assenagon Asset Management S.A. now owns 4,090 shares of the insurance provider’s stock worth $1,295,000 after purchasing an additional 461 shares during the period. Creative Financial Designs Inc. ADV increased its holdings in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the period. CacheTech Inc. increased its stake in Humana by 5.7% in the third quarter. CacheTech Inc. now owns 7,818 shares of the insurance provider’s stock valued at $2,476,000 after acquiring an additional 422 shares during the last quarter. Ceredex Value Advisors LLC increased its stake in Humana by 21.6% in the third quarter. Ceredex Value Advisors LLC now owns 360,374 shares of the insurance provider’s stock valued at $114,462,000 after acquiring an additional 64,118 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in Humana by 11.6% in the third quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider’s stock valued at $1,179,000 after acquiring an additional 388 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently commented on the company. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Piper Sandler increased their target price on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research note on Wednesday, January 15th. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. TD Cowen increased their target price on Humana from $261.00 to $268.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, StockNews.com raised Humana from a “hold” rating to a “buy” rating in a research note on Tuesday, February 25th. Nineteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $285.68.

Humana Stock Performance

Humana stock opened at $270.91 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a 50-day moving average of $271.11 and a 200-day moving average of $286.85. The firm has a market cap of $32.68 billion, a P/E ratio of 27.23, a P/E/G ratio of 2.05 and a beta of 0.56. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.31%. Humana’s dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.